Taken altogether, these findings reveal the clinical significance of WDFY3‐AS2 and the essential roles of WDFY3‐AS2/miR‐2355‐5p/SOCS2 signalling axis in ESCC development and progression. This evidence concerns the gene WDFY3 and esophageal squamous cell carcinoma.